Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Relative impact characteristic curve: a graphical tool to visualize and quantify the clinical utility and population-level consequences of implementing markers.

Sadatsafavi M, Gustafson P, Zafari Z, Sin DD.

Ann Epidemiol. 2018 Jul 30. pii: S1047-2797(18)30005-X. doi: 10.1016/j.annepidem.2018.07.014. [Epub ahead of print]

2.

The diagnostic performance of patient symptoms in screening for COPD.

Johnson KM, Tan WC, Bourbeau J, Sin DD, Sadatsafavi M; Canadian Cohort of Obstructive Lung Disease (CanCOLD) study and the Canadian Respiratory Research Network.

Respir Res. 2018 Aug 3;19(1):147. doi: 10.1186/s12931-018-0853-5.

3.

Asthma is not associated with the need for surgery in Crohn's disease when controlling for smoking status: a population-based cohort study.

Kuenzig ME, Sadatsafavi M, Aviña-Zubieta JA, Burne RM, Abrahamowicz M, Beauchamp ME, Kaplan GG, Benchimol EI.

Clin Epidemiol. 2018 Jul 12;10:831-840. doi: 10.2147/CLEP.S156772. eCollection 2018.

4.

Long-Term Trajectories of Mild Asthma in Adulthood and Risk Factors of Progression.

Chen W, FitzGerald JM, Lynd LD, Sin DD, Sadatsafavi M.

J Allergy Clin Immunol Pract. 2018 May 7. pii: S2213-2198(18)30304-0. doi: 10.1016/j.jaip.2018.04.027. [Epub ahead of print]

PMID:
29746917
5.

The projected economic and health burden of sub-optimal asthma control in Canada.

Zafari Z, Sadatsafavi M, Chen W, FitzGerald JM.

Respir Med. 2018 May;138:7-12. doi: 10.1016/j.rmed.2018.03.018. Epub 2018 Mar 16.

PMID:
29724396
6.

Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.

McCormick N, Marra CA, Sadatsafavi M, Aviña-Zubieta JA.

Lupus. 2018 Jul;27(8):1247-1258. doi: 10.1177/0961203318768882. Epub 2018 Apr 17.

PMID:
29665755
7.

Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjogren's Syndrome: A General Population-Based Study.

McCormick N, Marra CA, Sadatsafavi M, Kopec JA, Aviña-Zubieta JA.

Arthritis Care Res (Hoboken). 2018 Apr 12. doi: 10.1002/acr.23573. [Epub ahead of print]

PMID:
29648677
8.

The Impact of Care Specialty on Survival-Adjusted Medical Costs of COPD Patients After a Hospitalization: a longitudinal analysis.

Chen W, Sin DD, FitzGerald JM, Sadatsafavi M; Canadian Respiratory Research Network.

J Gen Intern Med. 2018 Sep;33(9):1528-1535. doi: 10.1007/s11606-018-4406-x. Epub 2018 Apr 2.

PMID:
29611088
9.

Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.

Tsao NW, Sayre EC, Hanley G, Sadatsafavi M, Lynd LD, Marra CA, De Vera MA.

Ann Rheum Dis. 2018 Jun;77(6):869-874. doi: 10.1136/annrheumdis-2018-213023. Epub 2018 Mar 1.

PMID:
29496718
10.

The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial.

Johnston JC, van der Kop ML, Smillie K, Ogilvie G, Marra F, Sadatsafavi M, Romanowski K, Budd MA, Hajek J, Cook V, Lester RT.

Eur Respir J. 2018 Feb 7;51(2). pii: 1701488. doi: 10.1183/13993003.01488-2017. Print 2018 Feb.

PMID:
29437940
11.

Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study.

Tavakoli H, Mark FitzGerald J, Lynd LD, Sadatsafavi M.

BMC Pulm Med. 2018 Feb 12;18(1):33. doi: 10.1186/s12890-018-0598-4.

12.

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US.

Zafari Z, Sadatsafavi M, Mark FitzGerald J; Canadian Respiratory Research Network.

Cost Eff Resour Alloc. 2018 Jan 30;16:3. doi: 10.1186/s12962-018-0089-8. eCollection 2018.

13.

Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Johnson KM, Bryan S, Ghanbarian S, Sin DD, Sadatsafavi M.

Respir Res. 2018 Feb 7;19(1):26. doi: 10.1186/s12931-018-0731-1.

14.

Response.

Raymakers AJN, Sadatsafavi M, Sin DD, De Vera MA, Lynd LD.

Chest. 2018 Feb;153(2):578-579. doi: 10.1016/j.chest.2017.12.006. No abstract available.

PMID:
29406228
15.

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology.

Sadatsafavi M, Xie H, Etminan M, Johnson K, FitzGerald JM; Canadian Respiratory Research Network.

PLoS One. 2018 Jan 19;13(1):e0191243. doi: 10.1371/journal.pone.0191243. eCollection 2018.

16.

Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.

Campbell JR, Johnston JC, Sadatsafavi M, Cook VJ, Elwood RK, Marra F.

PLoS One. 2017 Oct 30;12(10):e0186778. doi: 10.1371/journal.pone.0186778. eCollection 2017.

17.

Risk of Incident Chronic Obstructive Pulmonary Disease in Rheumatoid Arthritis: A Population-Based Cohort Study.

Mcguire K, Aviña-Zubieta JA, Esdaile JM, Sadatsafavi M, Sayre EC, Abrahamowicz M, Lacaille D.

Arthritis Care Res (Hoboken). 2017 Oct 19. doi: 10.1002/acr.23410. [Epub ahead of print]

PMID:
29047218
18.

Plexiform Schwannoma of the Finger: A Case Report and Literature Review.

Mortazavi N, Novin K, Zerehpoosh FB, Sadatsafavi M.

Indian Dermatol Online J. 2017 Sep-Oct;8(5):355-357. doi: 10.4103/idoj.IDOJ_370_16.

19.

Patterns of Biologics Utilization and Discontinuation Before and During Pregnancy in Women With Autoimmune Diseases: A Population-Based Cohort Study.

Tsao NW, Lynd LD, Sadatsafavi M, Hanley G, De Vera MA.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):979-986. doi: 10.1002/acr.23434. Epub 2018 Apr 30.

PMID:
28973840
20.

The impact of inappropriate use of short acting beta agonists in asthma.

FitzGerald JM, Tavakoli H, Lynd LD, Al Efraij K, Sadatsafavi M.

Respir Med. 2017 Oct;131:135-140. doi: 10.1016/j.rmed.2017.08.014. Epub 2017 Aug 17.

PMID:
28947020

Supplemental Content

Loading ...
Support Center